Floatz logo

bmd006

Lung Metastasis

Cancer Institute and Hospital, Chinese Academy of Medical SciencesEarly Phase 1Active
C
39/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
24/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Lung Metastasis cohort.

Asset / SponsorPhaseRating
Photofrin II
Taoyuan General Hospital
Phase 1CCC
MITOMYCIN C
Seoul National University Hospital
Phase 2CCC
FLUOROURACILUM
Seoul National University Hospital
Phase 2CCC
Ethiodized Oil
Taoyuan General Hospital
Early Phase 1C

Same molecule, other indications

bmd006 is also rated in:

cancerDormant
CC
Indicative ·
45 / 100
View asset →
metastatic malignant neoplasmDormant
CC
Indicative ·
43 / 100
View asset →
Advanced Solid TumorsDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →